Skip to main content
Erschienen in: European Journal of Nutrition 2/2013

01.03.2013 | Original Contribution

Vitamin C-related nutrient–nutrient and nutrient–gene interactions that modify folate status

verfasst von: Mark Lucock, Zoë Yates, Lyndell Boyd, Charlotte Naylor, Jeong-Hwa Choi, Xiaowei Ng, Virginia Skinner, Ron Wai, Jeremy Kho, Sa Tang, Paul Roach, Martin Veysey

Erschienen in: European Journal of Nutrition | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Folate-related nutrient–nutrient and nutrient–gene interactions modify disease risk; we therefore examined synergistic relationships between dietary folic acid, vitamin C and variant folate genes with respect to red cell folate status.

Methods

Two hundred and twelve subjects were examined using chemiluminescent immunoassay, PCR and food frequency questionnaire to determine red cell and serum folate, 14 folate gene polymorphisms, dietary folate (natural and synthetic) and vitamin C.

Results

When examined independently, synthetic PteGlu correlates best with red cell folate at higher levels of intake (p = 0.0102), while natural 5CH3-H4-PteGlun correlates best with red cell folate at lower levels of intake (p = 0.0035). However, dietary vitamin C and 5CH3-H4-PteGlun interact synergistically to correlate with red cell folate at higher levels of intake (p = 0.0005). No interaction between dietary vitamin C and PteGlu was observed. This ‘natural’ nutrient–nutrient interaction may provide an alternative to synthetic PteGlu supplementation that is now linked to adverse phenomena/health outcomes. On its own, vitamin C also correlates with red cell folate (p = 0.0150) and is strongly influenced by genetic variation in TS, MTHFR and MSR, genes critical for DNA and methionine biosynthesis that underpin erythropoiesis. Similarly, dietary vitamin C and 5CH3-H4-PteGlun act synergistically to modify red cell folate status according to variation in folate genes: of note, heterozygosity for 2R3R-TS (p = 0.0181), SHMT (p = 0.0046) and all three MTHFR SNPs (p = 0.0023, 0.0015 and 0.0239 for G1793A, C677T and A1298C variants, respectively) promote a significant association with red cell folate. Again, all these genes are critical for nucleic acid biosynthesis. Folate variants with the strongest independent effect on folate status were C677T-MTHFR (p = 0.0004) and G1793A-MTHFR (p = 0.0173).

Conclusions

5CH3-H4-PteGlun assimilation and variant folate gene expression products may be critically dependent on dietary vitamin C.
Literatur
1.
Zurück zum Zitat Gregory JF III (2001) Case study: folate bioavailability. J Nutr 131:1376–1382 Gregory JF III (2001) Case study: folate bioavailability. J Nutr 131:1376–1382
2.
Zurück zum Zitat Lucock M (2004) Clinical review science, medicine, and the future: is folic acid the ultimate functional food component for disease prevention? Br Med J 328:211–214CrossRef Lucock M (2004) Clinical review science, medicine, and the future: is folic acid the ultimate functional food component for disease prevention? Br Med J 328:211–214CrossRef
3.
Zurück zum Zitat Gregory JF III (1997) Bioavailability of folate. Eur J Clin Nutr 51:54–59CrossRef Gregory JF III (1997) Bioavailability of folate. Eur J Clin Nutr 51:54–59CrossRef
4.
Zurück zum Zitat Sauberlich HE, Kretsch MJ, Skalah JH, Johnson HL, Talyor PC (1987) Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 46:1016–1028 Sauberlich HE, Kretsch MJ, Skalah JH, Johnson HL, Talyor PC (1987) Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 46:1016–1028
6.
Zurück zum Zitat Keagy PM (1985) Folacin: microbiological and animal assays. In: Methods of vitamin assay, 4th edn. Wiley, New York, pp 445–471 Keagy PM (1985) Folacin: microbiological and animal assays. In: Methods of vitamin assay, 4th edn. Wiley, New York, pp 445–471
7.
Zurück zum Zitat Blakeley RL (1969) The chemistry of folic acid and related pteridines. Front Biol 13:58–105 Blakeley RL (1969) The chemistry of folic acid and related pteridines. Front Biol 13:58–105
8.
Zurück zum Zitat Murphy M, Keating M, Boyle P, Weir DG, Scott JM (1976) The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun 71:1017–1024CrossRef Murphy M, Keating M, Boyle P, Weir DG, Scott JM (1976) The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun 71:1017–1024CrossRef
9.
Zurück zum Zitat Murphy M, Boyle PHM, Weir DG, Scott JM (1978) The identification of the products of folate catabolism in the rat. Br J Haematol 38:211–218CrossRef Murphy M, Boyle PHM, Weir DG, Scott JM (1978) The identification of the products of folate catabolism in the rat. Br J Haematol 38:211–218CrossRef
10.
Zurück zum Zitat Scott JM (2001) Methyltetrahydrofolate: the superior alternative to folic acid. In: Nutraceuticals in health and disease prevention. Marcel Dekker, New York, pp 75–90 Scott JM (2001) Methyltetrahydrofolate: the superior alternative to folic acid. In: Nutraceuticals in health and disease prevention. Marcel Dekker, New York, pp 75–90
11.
Zurück zum Zitat Ng X, Lucock MD, Veysey M (2008) Physicochemical effect of pH and antioxidants on mono- and triglutamate forms of 5-methyltetrahydrofolate, and evaluation of vitamin stability in human gastric juice: Implications for folate bioavailability. Food Chem 106:200–210CrossRef Ng X, Lucock MD, Veysey M (2008) Physicochemical effect of pH and antioxidants on mono- and triglutamate forms of 5-methyltetrahydrofolate, and evaluation of vitamin stability in human gastric juice: Implications for folate bioavailability. Food Chem 106:200–210CrossRef
12.
Zurück zum Zitat Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI (1995) Non-enzymatic degradation and salvage of dietary folate: physico-chemical factors likely to influence bioavailability. Biochem Mol Med 55:43–53CrossRef Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI (1995) Non-enzymatic degradation and salvage of dietary folate: physico-chemical factors likely to influence bioavailability. Biochem Mol Med 55:43–53CrossRef
13.
Zurück zum Zitat Giovannucci E (2004) Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr 134:2475S–2481S Giovannucci E (2004) Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr 134:2475S–2481S
14.
Zurück zum Zitat Kim YI (2004) Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13:511–519 Kim YI (2004) Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13:511–519
15.
Zurück zum Zitat Fallon UB (2003) Colon cancer, folate and genetic status. Int J Epidemiol 32:67–70CrossRef Fallon UB (2003) Colon cancer, folate and genetic status. Int J Epidemiol 32:67–70CrossRef
16.
Zurück zum Zitat Lucock MD, Yates ZR (2009) Folic acid fortification: a double-edged sword. Curr Opin Clin Nutr Metab Care 12:555–564CrossRef Lucock MD, Yates ZR (2009) Folic acid fortification: a double-edged sword. Curr Opin Clin Nutr Metab Care 12:555–564CrossRef
17.
Zurück zum Zitat MRC Vitamin Study Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–137CrossRef MRC Vitamin Study Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–137CrossRef
18.
Zurück zum Zitat Smith DA, Kim YI, Refsum H (2008) Is folic acid good for everyone? Am J Clin Nutr 87:517–533 Smith DA, Kim YI, Refsum H (2008) Is folic acid good for everyone? Am J Clin Nutr 87:517–533
19.
Zurück zum Zitat Ulrich CM, Potter JD (2007) Folate and cancer—timing is everything. JAMA 297:2408–2409CrossRef Ulrich CM, Potter JD (2007) Folate and cancer—timing is everything. JAMA 297:2408–2409CrossRef
21.
Zurück zum Zitat Wright AJ, Dainty JR, Finglas PM (2007) Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr 98:667–675CrossRef Wright AJ, Dainty JR, Finglas PM (2007) Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr 98:667–675CrossRef
22.
Zurück zum Zitat Bailey SW, Ayling JE (2009) The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA 106:15424–15429CrossRef Bailey SW, Ayling JE (2009) The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA 106:15424–15429CrossRef
23.
Zurück zum Zitat Pickell L, Brown K, Li D, Wang XL, Deng L, Wu Q, Selhub J, Luo L, Jerome-Majewska L, Rozen R (2010) High intake of folic acid disrupts embryonic development in mice. Birth Defects Res A Clin Mol Teratol 91:8–19CrossRef Pickell L, Brown K, Li D, Wang XL, Deng L, Wu Q, Selhub J, Luo L, Jerome-Majewska L, Rozen R (2010) High intake of folic acid disrupts embryonic development in mice. Birth Defects Res A Clin Mol Teratol 91:8–19CrossRef
24.
Zurück zum Zitat Offer T, Ames BN, Bailey SW, Sabens EA, Nozawa M, Ayling JE (2007) 5-Methyltetrahydrofolate inhibits photosensitization reactions and strand breaks in DNA. FASEB J 21:2101–2107CrossRef Offer T, Ames BN, Bailey SW, Sabens EA, Nozawa M, Ayling JE (2007) 5-Methyltetrahydrofolate inhibits photosensitization reactions and strand breaks in DNA. FASEB J 21:2101–2107CrossRef
25.
Zurück zum Zitat Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070CrossRef Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070CrossRef
26.
Zurück zum Zitat Van der Put NMJ, Van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JM, Eskes TK, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ (1997) Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in NTD and vascular disease. Q J Med 90:511–517CrossRef Van der Put NMJ, Van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JM, Eskes TK, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ (1997) Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in NTD and vascular disease. Q J Med 90:511–517CrossRef
27.
Zurück zum Zitat Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62:1044–1051CrossRef Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am J Hum Genet 62:1044–1051CrossRef
28.
Zurück zum Zitat Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S (2004) New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 124:339–345CrossRef Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S (2004) New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 124:339–345CrossRef
29.
Zurück zum Zitat Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fodinger M (2003) Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63:2280–2285CrossRef Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fodinger M (2003) Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63:2280–2285CrossRef
30.
Zurück zum Zitat Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317–323CrossRef Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317–323CrossRef
31.
Zurück zum Zitat Melse-Boonstra A, Lievers KJ, Blom HJ, Verhoef P (2004) Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. Am J Clin Nutr 80:700–704 Melse-Boonstra A, Lievers KJ, Blom HJ, Verhoef P (2004) Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. Am J Clin Nutr 80:700–704
32.
Zurück zum Zitat Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK (2002) Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107:162–168CrossRef Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK (2002) Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107:162–168CrossRef
33.
Zurück zum Zitat Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R (2002) Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 100:718–720CrossRef Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R (2002) Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 100:718–720CrossRef
34.
Zurück zum Zitat Pietrzyk JJ, Bik-Multanowski M (2003) 776C>G polymorphism of the transcobalamin II gene as a risk factor for spina bifida. Mol Genet Metab 80:364CrossRef Pietrzyk JJ, Bik-Multanowski M (2003) 776C>G polymorphism of the transcobalamin II gene as a risk factor for spina bifida. Mol Genet Metab 80:364CrossRef
35.
Zurück zum Zitat Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ (1996) High prevalence of a mutation in the cystathionine beta-synthase gene. Am J Hum Genet 59:1262–1267 Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ (1996) High prevalence of a mutation in the cystathionine beta-synthase gene. Am J Hum Genet 59:1262–1267
36.
Zurück zum Zitat Heil SG, Van der Put NM, Waas ET, den Heijer M, Trijbels FJ, Blom HJ (2001) Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73:164–172CrossRef Heil SG, Van der Put NM, Waas ET, den Heijer M, Trijbels FJ, Blom HJ (2001) Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73:164–172CrossRef
37.
Zurück zum Zitat Horie N, Aiba H, Oguro K, Hojo H, Takeishi K (1995) Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20:191–197CrossRef Horie N, Aiba H, Oguro K, Hojo H, Takeishi K (1995) Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20:191–197CrossRef
38.
Zurück zum Zitat Tan W, Miao X, Wang L, Yu C, Xiong P, Liang G, Sun T, Zhou Y, Zhang X, Li H, Lin D (2005) Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis 26:1430–1435CrossRef Tan W, Miao X, Wang L, Yu C, Xiong P, Liang G, Sun T, Zhou Y, Zhang X, Li H, Lin D (2005) Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis 26:1430–1435CrossRef
39.
Zurück zum Zitat Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD (2000) Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 9:1381–1385 Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD (2000) Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 9:1381–1385
40.
Zurück zum Zitat Mosharov E, Cranford MR, Banerjee R (2000) The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39:13005–13011CrossRef Mosharov E, Cranford MR, Banerjee R (2000) The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39:13005–13011CrossRef
41.
Zurück zum Zitat Lucock M (2004) Is folic acid the ultimate functional food component for disease prevention? Br Med J 328:211–214CrossRef Lucock M (2004) Is folic acid the ultimate functional food component for disease prevention? Br Med J 328:211–214CrossRef
42.
Zurück zum Zitat Matthews RG, Haywood BJ (1979) Inhibition of pig liver methylenetetrahydrofolate reductase by dihydrofolate: some mechanistic and regulatory implications. Biochemistry 18:4845–4851CrossRef Matthews RG, Haywood BJ (1979) Inhibition of pig liver methylenetetrahydrofolate reductase by dihydrofolate: some mechanistic and regulatory implications. Biochemistry 18:4845–4851CrossRef
Metadaten
Titel
Vitamin C-related nutrient–nutrient and nutrient–gene interactions that modify folate status
verfasst von
Mark Lucock
Zoë Yates
Lyndell Boyd
Charlotte Naylor
Jeong-Hwa Choi
Xiaowei Ng
Virginia Skinner
Ron Wai
Jeremy Kho
Sa Tang
Paul Roach
Martin Veysey
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 2/2013
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-012-0359-8

Weitere Artikel der Ausgabe 2/2013

European Journal of Nutrition 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.